Home Newsfeeds Raymond James Maintains Outperform on PetIQ, Lowers Price Target to $21

Raymond James Maintains Outperform on PetIQ, Lowers Price Target to $21

Raymond James analyst Elliot Wilbur maintains PetIQ (NASDAQ:PETQ) with a Outperform and lowers the price target from $29 to $21.

byBenzinga Newsdesk

August 10, 2022

1 minute read

Raymond James analyst Elliot Wilbur maintains PetIQ (NASDAQ:PETQ) with a Outperform and lowers the price target from $29 to $21.

Soligenix Invited To Submit BARDA Contract Proposal For Development Of Thermostabilized Subunit Vaccines For Sudan Ebola And Marburg Viruses

By Benzinga Newsdesk

October 27, 7:33 AM

Emerging infectious diseases where no protective vaccines are currently available SuVax™ targets Sudan ebolavirus, origin of a current disease outbreak in Uganda

SNGX

Amalgamated Bank Q3 Adj EPS $0.80 Beats $0.69 Estimate, Sales $72.63M Beat $66.25M Estimate

By Benzinga Newsdesk

October 27, 6:28 AM

Amalgamated Bank (NASDAQ:AMAL) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.69 by 15.94 percent. This is a 73.91 percent increase over earnings of $0.46 per share from

AMAL

News
Tech

Elon Musk Dangles ‘One-Off’ Amnesty To Tesla Customers For FSD Transfer: ‘I Hope This Makes People Happy’

By Anan Ashraf

July 19, 11:05 PM

EV giant Tesla Inc (NASDAQ:TSLA) said on Wednesday that it will be allowing the transferability of its full-self…

TSLA

Halozyme Therapeutics +13% On Thursday: What’s Going On?

By Nabaparna Bhattacharya

June 6, 12:34 PM

Halozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for its drug delivery platform.

HALO

Raymond James Maintains Outperform on PetIQ, Lowers Price Target to $21

Related Posts

Soligenix Invited To Submit BARDA Contract Proposal For Development Of Thermostabilized Subunit Vaccines For Sudan Ebola And Marburg Viruses

Amalgamated Bank Q3 Adj EPS $0.80 Beats $0.69 Estimate, Sales $72.63M Beat $66.25M Estimate

Elon Musk Dangles ‘One-Off’ Amnesty To Tesla Customers For FSD Transfer: ‘I Hope This Makes People Happy’

Halozyme Therapeutics +13% On Thursday: What’s Going On?